146 related articles for article (PubMed ID: 30659293)
1. Pre- and post-radical prostatectomy testosterone levels in prostate cancer patients.
Lumbiganon S; Patcharatrakul S; Khongcharoensombat W; Sangkum P
Int J Impot Res; 2019 Mar; 31(2):145-149. PubMed ID: 30659293
[TBL] [Abstract][Full Text] [Related]
2. Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.
Dai B; Qu Y; Kong Y; Ye D; Yao X; Zhang S; Wang C; Zhang H; Yang W
BJU Int; 2012 Dec; 110(11 Pt B):E667-72. PubMed ID: 22974446
[TBL] [Abstract][Full Text] [Related]
3. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.
Gao Y; Jiang CY; Mao SK; Cui D; Hao KY; Zhao W; Jiang Q; Ruan Y; Xia SJ; Han BM
Asian J Androl; 2016; 18(4):639-43. PubMed ID: 26732103
[TBL] [Abstract][Full Text] [Related]
4. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
5. Serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.
Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Cocco C; Romano M; Cavalleri S; Artibani W
Urol Int; 2013; 91(1):55-61. PubMed ID: 23751412
[TBL] [Abstract][Full Text] [Related]
6. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer.
Teloken C; Da Ros CT; Caraver F; Weber FA; Cavalheiro AP; Graziottin TM
J Urol; 2005 Dec; 174(6):2178-80. PubMed ID: 16280759
[TBL] [Abstract][Full Text] [Related]
7. Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results.
Neuzillet Y; Raynaud JP; Dreyfus JF; Radulescu C; Rouanne M; Schneider M; Krish S; Rouprêt M; Drouin SJ; Comperat E; Galiano M; Cathelineau X; Validire P; Molinié V; Fiet J; Giton F; Lebret T; Botto H
Horm Cancer; 2019 Feb; 10(1):36-44. PubMed ID: 30293206
[TBL] [Abstract][Full Text] [Related]
8. Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer.
Schnoeller T; Jentzmik F; Rinnab L; Cronauer MV; Damjanoski I; Zengerling F; Ghazal AA; Schrader M; Schrader AJ
World J Urol; 2013 Apr; 31(2):253-9. PubMed ID: 22763628
[TBL] [Abstract][Full Text] [Related]
9. Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading.
Pichon A; Neuzillet Y; Botto H; Raynaud JP; Radulescu C; Molinié V; Herve JM; Lebret T
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):382-7. PubMed ID: 26439747
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy.
Yamamoto S; Yonese J; Kawakami S; Ohkubo Y; Tatokoro M; Komai Y; Takeshita H; Ishikawa Y; Fukui I
Eur Urol; 2007 Sep; 52(3):696-701. PubMed ID: 17412490
[TBL] [Abstract][Full Text] [Related]
11. Preoperative hormonal pattern in patients undergoing radical prostatectomy due to prostate cancer.
García-Cruz E; Castañeda-Argáiz R; Carrión A; Alcover J; Sallent A; Leibar-Tamayo A; Romero-Otero J; Alcaraz A;
Actas Urol Esp; 2013 May; 37(5):280-5. PubMed ID: 23246101
[TBL] [Abstract][Full Text] [Related]
12. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
13. Absence of relationship between steroid hormone levels and prostate cancer tumor grade.
Sher DJ; Mantzoros C; Jacobus S; Regan MM; Lee GS; Oh WK
Urology; 2009 Feb; 73(2):356-61; discussion 361-2. PubMed ID: 19036418
[TBL] [Abstract][Full Text] [Related]
14. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer.
Hsieh TF; Chang CH; Chen WC; Chou CL; Chen CC; Wu HC
J Chin Med Assoc; 2005 Apr; 68(4):167-71. PubMed ID: 15850066
[TBL] [Abstract][Full Text] [Related]
16. Serum inhibin--not a cause of low testosterone levels in hypogonadal prostate cancer?
Lackner JE; Maerk I; Koller A; Bieglmayer C; Marberger M; Kratzik C; Schatzl G
Urology; 2008 Nov; 72(5):1121-4. PubMed ID: 18407338
[TBL] [Abstract][Full Text] [Related]
17. The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6-A Study on 320 Patients After Radical Prostatectomy.
Dolejsova O; Kucera R; Fuchsova R; Topolcan O; Svobodova H; Hes O; Eret V; Pecen L; Hora M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818787377. PubMed ID: 30021484
[TBL] [Abstract][Full Text] [Related]
18. Investigative clinical study on prostate cancer part II: on the role of the pretreatment total PSA to free testosterone ratio as a marker assessing prostate cancer prognostic groups after radical retropubic prostatectomy.
Porcaro AB; Monaco C; Romano M; Petrozziello A; Rubilotta E; Lacola V; Sava T; Ghimenton C; Caruso B; Antoniolli SZ; Migliorini F; Comunale L
Urol Int; 2010; 85(2):152-8. PubMed ID: 20616526
[TBL] [Abstract][Full Text] [Related]
19. Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy.
Waldert M; Schatzl G; Swietek N; Rom M; Klatte T
J Urol; 2012 Sep; 188(3):792-7. PubMed ID: 22818139
[TBL] [Abstract][Full Text] [Related]
20. Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?
Imamoto T; Suzuki H; Yano M; Kawamura K; Kamiya N; Araki K; Komiya A; Naya Y; Shiraishi T; Ichikawa T
Prostate Cancer Prostatic Dis; 2009; 12(1):78-82. PubMed ID: 18521100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
